TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
AMPH

Amphastar Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

24.30$ -0.7% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Amphastar Pharmaceuticals, Inc. (AMPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,744 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AMPH
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,545 1,513 1,574 1,492 1,545 1,577 1,626 1,615 1,666 1,629 1,648 1,744
543 490 555 483 546 534 588 581 639 636 634 631
267 144 201 190 192 152 183 188 217 170 171 224
300 257 290 218 250 222 237 232 279 283 294 290
119 115 139 132 145 138 145 135 147 144 148 145
110 106 115 122 130 154 185 192 186 177 170 180
3.1 3.2 3.2 3.1 3.3 3.0 3.2 3.4 3.4 3.4 3.3 3.4
616 610 604 598 592 588 581 575 569 563 556 563
949 873 902 778 818 845 875 858 889 840 875 976
258 225 255 137 159 174 199 176 205 158 164 263
4.2 4.3 4.4 4.2 4.5 7.0 8.0 8.8 8.8 9.6 11 11
32 25 37 32 34 31 53 42 41 33 36 29
638 590 594 587 596 602 604 608 609 609 610 610
595 639 672 713 728 732 751 757 777 789 773 768
373 409 452 490 531 569 594 625 642 667 673 704
54 53 53 52 52 52 50 48 48 47 46 44

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?